# GenomiCare Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genomicare-biotechnology

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.genomicarebio.com
- Total disclosed funding: $30M
- Latest round: Series A (Dec 17, 2018)
- Investors on record: 6

## About

Based in Shanghai, China and established in 2015, GenomiCare Biotechnology is a medical services provider which focuses on tumor precision medicine, providing  filtering, implementation and monitoring of it for patients.

## Funding rounds

- Series A, Dec 17, 2018, $30M — GP Capital, Trustbridge Partners, General Oriental Investments
- Series A, Nov 30, 2017 — 5Y Capital, Apricot Capital, Jiaxin Holdings

## Investors

- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A
- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Series A
- Jiaxin Holdings — Series A
- GP Capital (https://capitalatlas.ai/funds/gp-capital) — Series A
- Trustbridge Partners (https://capitalatlas.ai/funds/trustbridge-partners) — Series A
- General Oriental Investments — Series A